InvestorsHub Logo
Followers 0
Posts 2283
Boards Moderated 0
Alias Born 01/31/2019

Re: None

Friday, 03/22/2019 1:06:16 PM

Friday, March 22, 2019 1:06:16 PM

Post# of 32923
$KALY - The U.S. FDA has recommended that Kalytera apply for both Breakthrough Therapy and Fast Track Designations for its CBD products for prevention and treatment of acute GVHD, each of which could accelerate the approval process for these products.

#BottomFishing #PotStocks